Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Lalla
    Junior Member
    • Apr 2015
    • 7

    #1

    FPKM interpretation

    Hi all!

    I am analyzing differential isoform expression between some samples. I run Cuffdiff2 and i found the differentially expressed isoforms. I also calculated the porportion of the expression of each isoform compared to the expression of the gene (the sum of the expressions of all the isoforms of that gene). Now I need to better filter my results. I was thinking to focus on the highly expressed isoforms and on those with a relevant proportion, but I couldn't find a criteria to choose a cutoff based on the FPKM. When can I say that a gene or isoform is highly expressed? And how can I understand when a proportion is relevant? I would think that the relevance of the proportion depends also on the total expression, i.e an isoform which account for the 30% of an highly expressed gene might be not as relevant as an isoform which account for the 30% of a low expressed gene, am i correct?
    I had a look to related posts in this forum and to several articles but i couldn't find a clear guidline. Maybe the answer is not simple but if you could suggest me some statistical approach to analyze these data would be great.
    Thanks in advance!
  • Lalla
    Junior Member
    • Apr 2015
    • 7

    #2
    FPKM interpretation

    Hi all!

    I am analyzing differential isoform expression between some samples. I run Cuffdiff2 and i found the differentially expressed isoforms. I also calculated the porportion of the expression of each isoform compared to the expression of the gene (the sum of the expressions of all the isoforms of that gene). Now I need to better filter my results. I was thinking to focus on the highly expressed isoforms and on those with a relevant proportion, but I couldn't find a criteria to choose a cutoff based on the FPKM. When can I say that a gene or isoform is highly expressed? And how can I understand when a proportion is relevant? I would think that the relevance of the proportion depends also on the total expression, i.e an isoform which account for the 30% of an highly expressed gene might be not as relevant as an isoform which account for the 30% of a low expressed gene, am i correct?
    I had a look to related posts in this forum and to several articles but i couldn't find a clear guidline. Maybe the answer is not simple but if you could suggest me some statistical approach to analyze these data would be great.
    Thanks in advance!

    Comment

    • bastianwur
      Member
      • Feb 2014
      • 98

      #3
      There's no good answer for this.
      Besides that I'd use the p/q value from the output, that's at least easy .

      Comment

      • Lalla
        Junior Member
        • Apr 2015
        • 7

        #4
        Thanks for your reply.
        Is not possible at all to do some sort of normalization per abundance in FPKM? If FPKM reflect the expression of transcripts in my sample I think there should be a way to find out the "significance" of a change in relative abundance of a transcript per total expression of a gene. Any suggestion is warmly welcomed!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          Yesterday, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 02:55 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...